IL0002240146
IL0002240146
CLAL INSURANCE ENT
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 22.19B EUR | 1.86T EUR | 1.79T EUR | 1.65T EUR |
Enterprise Value | -41.54B EUR | 1.87T EUR | 1.8T EUR | 1.66T EUR |
Valuation Multiples | ||||
Trailing P/E | 9.56x | 778.54x | 776.97x | 880.52x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 1.28x | 64.78x | 62.28x | 66.98x |
Price to Book | 192.03x | 160.87x | 164.12x | 152.08x |
EV/Revenue | -2.39x | 65.14x | 62.64x | 67.35x |
EV/EBITDA | -6.38x | -- | -- | -- |
Price to FCF (P/FCF) | -- | 1,126.71x | 2,800.73x | 1,100.65x |
EV/FCF | -- | 1,132.96x | 2,816.95x | 1,106.65x |
FCF Yield | -297.46% | 0.09% | 0.04% | 0.09% |